Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Island Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Clarity Pharma, Island Pharma set to embark on next steps of clinical trials
Health & Biotech
ASX Health Stocks: Island Pharma granted Aussie patent for flavivirus infection drug, ISLA-101
Health & Biotech
ASX Health Stocks: Starpharma jumps 30pc after cancer drug helps enable ‘100 per cent’ control rate
Health & Biotech
ASX Health Stocks: AdAlta jumps 40pc after its fibrosis drug shows ‘potential efficacy’ in humans
Health & Biotech
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
Health & Biotech
Which ASX stocks are on the path from FDA to clinical trial in 2023?
Health & Biotech
ASX Tech & Biotech: Island Pharma files investigational application for new Dengue Fever drug
Health & Biotech
ASX Health Stocks: Rhythm Bio taps Baker Institute as partner; Island Pharma gets ethics approval in US
Health & Biotech
ASX Health Stocks: New patent for Island Pharma in Canada; Nova Eye beats sales guidance
Health & Biotech
ASX Health Stocks: EMV jumps 7pc after delivering portable brain scanner; Firebrick gets Aussie patent
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
ASX Health Stocks: Neuroscientific says EmtinB shows positive signs, expects full results in H2
Escrow Watch
Escrow Watch: Which companies have shares coming out of escrow in April?
Health & Biotech
ASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slides into Greece
Health & Biotech
ASX Health Stocks: Pharmaxis jumps 9pc on FDA approval
Health & Biotech
ASX health stocks: CSL leads another round of strong earnings, but FY22 outlook remains subdued
Health & Biotech
